pretickt

CRISPR Therapeutics stock price history and statistics

CRISPR Therapeutics AG · end-of-day data as of Nov 13, 2026

CRISPR Therapeutics
CRSP · $4.1B
$42.24-0.9%
Nov 13, 2026 · close
$50$60SepOctNov9:3016:003 months -20.3%Nov 13 · close
▲ 4
  • PT$72.45 +71.5%
  • ConsensusBuy · 23
  • Bollingerbelow lower
  • Sector▲ +15.9%
Neutral
  • Earnings in90d
  • RSI32
  • Support-7.6%
  • Resistance+0.3%
  • Off 52w high-33.4%
  • Volume1.2x
  • News0.00
  • Trendsideways
  • 52w range$42–$63
  • ATR+6.3%
  • Off ATH-80.8%
▼ 4
  • FCF yield-9.3%
  • Insiders-$4.88M
  • MAs0 of 4
  • MACD-0.81

Updates with the 15-min delayed price. Not a forecast or investment advice.

CRISPR Therapeutics CRSP closed a month higher 27 times out of 59 in the last five years. It is 55.1% below its 5-year high close of $94.14 (Nov 8, 2021). Its deepest fall from a high was -66.8% (Nov 2021 → Apr 2025), not made back yet.

How much does CRISPR Therapeutics stock move?

±2.3%on a typical dayS&P 500 ±0.6%
43days a year it moved more than 5%S&P 500 fewer than 1
1.5×the market's daily moves (beta)When the S&P 500 moved 1%, CRISPR Therapeutics moved 1.5% on average, over two years
±20%in a typical monthHalf the spread of its middle 80% of one-month moves, in the last five years

CRISPR Therapeutics stock performance by year

2022-46.4%S&P -18.2%
2023+54.0%S&P +26.2%
2024-37.1%S&P +24.9%
2025+33.2%S&P +17.7%
2026 so far-19.5%S&P +11.5%

CRISPR TherapeuticsS&P 500

In the last five years: CRISPR Therapeutics -55.1%, S&P 500 +72.0%. 2026 is to Nov 13, 2026.

Falls and rises of 30% or more

8 falls of 30% or more in the last five years, and 7 rises of 30% or more. Today CRISPR Therapeutics is 55.1% below its 5-year high close of $94.14 (Nov 8, 2021) and at its 52-week low close of $42.24 (Nov 13, 2026).

$30$50$8020222023202420252026-43%+31%-38%+94%-53%+73%-43%+131%-57%+38%-41%+146%-40%+35%-32%

A fall of 30% or moreA rise of 30% or more

Falls of 30% or more

How many
8
Typical
-42.0%in about 4 months
Deepest from a high
-66.8%Nov 2021 → Apr 2025, not back yet
Latest
-31.7%Jul 2026 → Nov 2026, so far, not back yet

Rises of 30% or more

How many
7
Typical
+72.9%in about 4 months
Largest from a low
+145.5%Apr 2025 → Oct 2025
Latest
+34.9%Feb 2026 → Jul 2026

For scale, the S&P 500's deepest fall in the same years: -24.5%. A fall or a rise counts once the price turns back by 30%: 1.5 times CRISPR Therapeutics's typical month, rounded to 5%, never under 10%.

Will CRISPR Therapeutics stock go up?

In the last five years CRISPR Therapeutics closed a month higher 27 times out of 59. That is the past: pretickt does not forecast its direction.

CRISPR Therapeutics27/59
S&P 50037/59
46%of one-year stretches ended higherS&P 500 88%
46%of days closed higherS&P 500 53%
+71% / -26%best and worst monthNov 2023 · Dec 2022

From daily closing prices adjusted for splits and dividends. What happened in the past, not a forecast. For information only, not investment advice.